Primary Care Diabetes

Use of fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Asians with type 2 diabetes

By Alice Pik-Shan Kong, Chun Kwan O, Siran Lai, Chih-Yuan Wang, Juliana Chung-Ngor Chan

ReviewInterventions

The paper

Alice Pik-Shan Kong, Chun Kwan O, Siran Lai, Chih-Yuan Wang, Juliana Chung-Ngor Chan

Chinese University of Hong Kong

Primary Care Diabetes, 4 Sep 2026

doi.org/10.1016/j.pcd.2026.08.005 PubMed 42697752

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes